Good Science and Good Product: The Complexity of Biomedical Innovation

Innovation is critical to the future of healthcare, and it can lead to better patient outcomes, improved well-being, and overall better population health. Unfortunately, too many brilliant biomedical concepts never reach patients due to a lack of funding, technical difficulties, or legislative difficulties.

In this episode of the Building Biotechs series of the Biotech Innovators podcast, we welcome Kurt Gielen, the co-founder and chief business officer of Medace, a unique biomedical incubator committed to turning biomedical research into reality. He talks about the complex process of biomedical innovation, how Medace supports promising biotech startups, and the potential challenges these innovations may face.

This content is offered for informational purposes only. The opinions stated in this podcast are that of the speaker and do not constitute or imply an endorsement by Thermo Fisher Scientific.